Clinical Trials Directory

Trials / Completed

CompletedNCT02881931

FuRST 2.0 Cognitive Pre-Testing

FuRST 2.0: Cognitive Pre-Testing Study for a New Functional Rating Scale for Use in Huntington's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
CHDI Foundation, Inc. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The FuRST 2.0 scale is being developed as a Patient Reported Outcome (PRO) with information coming directly from the Huntington's Disease Gene Expansion Carrier (HDGEC) and companion through self-report. The purpose of this study is to identify real or potential comprehension or usage problems with questionnaire items or response options. Through a process of structured cognitive de-briefing with HDGEC participants and companions, independently, followed by qualitative analysis, the final phrasing of the individual items and response options for the scale will be generated. Depending on the results of the first round of cognitive pre-testing, additional rounds of cognitive pre-testing may be required.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFuRST 2.0Cognitive Pre-testing of new Functional Rating Scale

Timeline

Start date
2017-02-28
Primary completion
2017-07-28
Completion
2017-07-28
First posted
2016-08-29
Last updated
2017-08-08

Locations

4 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT02881931. Inclusion in this directory is not an endorsement.

FuRST 2.0 Cognitive Pre-Testing (NCT02881931) · Clinical Trials Directory